Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-16 4:21 pm Purchase | 2026-09-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Vestal Point Capital, LP | 7,130,000 8.400% | 2,530,000![]() (+55.00%) | Filing History |
| 2026-11-16 4:20 pm Sale | 2026-09-30 | 13G | MYRIAD GENETICS INC MYGN | Vestal Point Capital, LP | 0 0.000% | -5,735,000![]() (Position Closed) | Filing History |
| 2026-11-16 4:20 pm Sale | 2026-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Vestal Point Capital, LP | 7,025,000 6.400% | -1,025,000![]() (-12.73%) | Filing History |
| 2026-11-16 4:19 pm Purchase | 2026-09-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | Vestal Point Capital, LP | 3,000,000 8.100% | 1,500,000![]() (+100.00%) | Filing History |
| 2026-11-16 4:18 pm Sale | 2026-09-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Vestal Point Capital, LP | 3,225,000 4.400% | -25,000![]() (-0.77%) | Filing History |
| 2026-11-16 4:17 pm Sale | 2026-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Vestal Point Capital, LP | 0 0.000% | -2,470,096![]() (Position Closed) | Filing History |
| 2026-11-16 4:16 pm Purchase | 2026-09-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Vestal Point Capital, LP | 5,187,302 6.300% | 1,070,000![]() (+25.99%) | Filing History |
| 2026-11-16 4:15 pm Purchase | 2026-09-30 | 13G | IMMATICS N V IMTX | Vestal Point Capital, LP | 15,515,304 9.900% | 9,340,304![]() (+151.26%) | Filing History |
| 2026-08-14 4:10 pm Purchase | 2026-06-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Vestal Point Capital, LP | 4,600,000 5.400% | 4,600,000![]() (New Position) | Filing History |
| 2026-08-14 4:09 pm Purchase | 2026-06-30 | 13G | MYRIAD GENETICS INC MYGN | Vestal Point Capital, LP | 5,735,000 6.100% | 5,735,000![]() (New Position) | Filing History |
| 2026-08-14 4:08 pm Sale | 2026-06-30 | 13G | SOLID BIOSCIENCES INC SLDB | Vestal Point Capital, LP | 4,833,796 4.800% | -981,204![]() (-16.87%) | Filing History |
| 2026-08-14 4:08 pm Sale | 2026-06-30 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Vestal Point Capital, LP | 1,800,000 3.500% | -966,868![]() (-34.94%) | Filing History |
| 2026-08-14 4:07 pm Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Vestal Point Capital, LP | 8,050,000 7.800% | 1,550,000![]() (+23.85%) | Filing History |
| 2026-08-14 4:06 pm Sale | 2026-06-30 | 13G | ALTO NEUROSCIENCE INC ANRO | Vestal Point Capital, LP | 785,000 2.200% | -1,279,075![]() (-61.97%) | Filing History |
| 2026-08-14 4:05 pm Sale | 2026-06-30 | 13G | IBIO INC PAR $0.001 IBIO | Vestal Point Capital, LP | 4,025,000 7.900% | -250,000![]() (-5.85%) | Filing History |
| 2026-08-14 4:05 pm Sale | 2026-06-30 | 13G | PASSAGE BIO INC PASG | Vestal Point Capital, LP | 0 0.000% | -305,000![]() (Position Closed) | Filing History |
| 2026-05-15 5:09 pm Purchase | 2026-03-31 | 13G | TAYSHA GENE THERAPIES INC TSHA | Vestal Point Capital, LP | 18,000,000 6.300% | 4,250,000![]() (+30.91%) | Filing History |
| 2026-05-15 5:06 pm Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Vestal Point Capital, LP | 5,425,000 8.300% | 1,850,000![]() (+51.75%) | Filing History |
| 2026-05-15 5:05 pm Sale | 2026-03-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Vestal Point Capital, LP | 3,250,000 5.400% | -580,000![]() (-15.14%) | Filing History |
| 2026-05-15 5:05 pm Sale | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Vestal Point Capital, LP | 2,064,075 6.500% | -420,925![]() (-16.94%) | Filing History |

